Analyst Scoreboard: 5 Ratings For Clene
Portfolio Pulse from Benzinga Insights
In the past three months, 5 analysts have rated Clene (NASDAQ:CLNN), all with bullish sentiments. The average 12-month price target has increased to $6.6. Clene faces financial challenges, including a revenue decline of -31.78%, a net margin of -15178.08%, and a high debt-to-equity ratio of 7.61.
June 18, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Clene (NASDAQ:CLNN) received 5 bullish ratings from analysts in the past three months, with an average price target of $6.6. Despite positive analyst sentiment, Clene faces significant financial challenges, including a -31.78% revenue decline, a net margin of -15178.08%, and a high debt-to-equity ratio of 7.61.
While the bullish ratings and increased price target indicate positive sentiment from analysts, the significant financial challenges such as revenue decline, poor net margin, and high debt levels suggest a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100